Perspectives on Enquiry & Evidence
Cytel's blog featuring the latest industry insights.
March 15, 2019
Quantitative pharmacology encompasses the many strategic advantages of using complex mathematical models to understand...
Read article
February 28, 2019
Statistical Approaches to Overcome Challenges in Rare Disease Development
In honor of Rare Disease Day 2019 we share a new Cytel podcast featuring Cytel Strategic Consultant Ursula Garczarek...
Read article
February 21, 2019
Podcast with Ursula Garczarek on The Effective Statistician
In 2018, Cytel ran a qualitative survey among biostatisticians and programmers on trends in data science and...
Read article
January 30, 2019
Career Perspectives: Interview with Tina Checchio, Associate Director, Quantitative Pharmacology & Pharmacometrics
QPP remains at the heart of model based drug development. Short for Quantitative Pharmacology & Pharmacometrics, it...
Read article
January 10, 2019
Podcast: Overcoming Phase 1 Development Challenges
Nand Kishore Rawat is a Director and Head, Early Phase Biostatistics based in the King of Prussia, PA Cytel office. We...
Read article
August 8, 2018
How can a strategic pharmacometrics consultant add value to your team?
We have written on the blog in the past about the value that a statistical consultant can bring to your team, and to...
Read article
May 31, 2018
5 Reasons to Integrate MBMA Into Your Clinical Development Strategy
By Esha Senchaudhuri An important trend in clinical development involves integrating strategic pharmacometric analysis...
Read article
April 3, 2018
Maximizing Preclinical Knowledge for Optimal R&D
By Esha Senchaudhuri In response to its R&D productivity from 2005 – 2010, AstraZeneca took the initiative in 2011 to...
Read article